Parisi, Ernesta

Acute myelogenous leukemia: advances and limitations of treatment. [electronic resource] - Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics Mar 2002 - 257-63 p. digital

Publication Type: Case Reports; Comparative Study; Journal Article; Review

1079-2104

10.1067/moe.2002.121988 doi


Adult
Aminoglycosides
Anthracyclines--therapeutic use
Anti-Bacterial Agents--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antigens, CD--metabolism
Antigens, Differentiation, Myelomonocytic--metabolism
Antimetabolites, Antineoplastic--therapeutic use
Antineoplastic Agents--therapeutic use
Benzamides
Case-Control Studies
Cytarabine--therapeutic use
Fatal Outcome
Gemtuzumab
Gingiva--pathology
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Immunosuppressive Agents--therapeutic use
Immunotoxins--therapeutic use
Leukemia, Myeloid, Acute--therapy
Leukemic Infiltration
Male
Piperazines--therapeutic use
Pyrimidines--therapeutic use
Remission Induction
Sialic Acid Binding Ig-like Lectin 3